Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-18

Clinical Trial Update: Beta Glucosylceramide for Treatment of NASH [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Beta Glucosylceramide for non-alcoholic steatohepatitis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beta Glucosylceramide (beta-glucosylceramide)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Compliance Behavior | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-08-18